References
1. Control CfD, Prevention. Estimated influenza illnesses and
hospitalizations averted by influenza vaccination-United States, 2012-13
influenza season. MMWR Morbidity and mortality weekly report.2013;62(49):997.
2. Sugaya N, Shinjoh M, Nakata Y, et al. Three-season effectiveness of
inactivated influenza vaccine in preventing influenza illness and
hospitalization in children in Japan, 2013–2016. Vaccine.2018;36(8):1063-1071.
3. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical
signs and symptoms predicting influenza infection. Archives of
internal medicine. 2000;160(21):3243-3247.
4. Eccles R. Understanding the symptoms of the common cold and
influenza. The Lancet infectious diseases. 2005;5(11):718-725.
5. Cohen AL, Hellferscee O, Pretorius M, et al. Epidemiology of
influenza virus types and subtypes in South Africa, 2009–2012.Emerging infectious diseases. 2014;20(7):1162.
6. Wagner R, Matrosovich M, Klenk HD. Functional balance between
haemagglutinin and neuraminidase in influenza virus infections.Reviews in medical virology. 2002;12(3):159-166.
7. Yang H, Carney PJ, Mishin VP, et al. The molecular characterizations
of surface proteins hemagglutinin and neuraminidase from recent H5Nx
avian influenza viruses. Journal of virology. 2016:JVI.
00180-00116.
8. Kallewaard NL, Corti D, Collins PJ, et al. Structure and function
analysis of an antibody recognizing all influenza A subtypes.Cell. 2016;166(3):596-608.
9. Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of
influenza B: a structured literature review. American journal of
public health. 2013;103(3):e43-e51.
10. Irving SA, Patel DC, Kieke BA, et al. Comparison of clinical
features and outcomes of medically attended influenza A and influenza B
in a defined population over four seasons: 2004–2005 through
2007–2008. Influenza and other respiratory viruses.2012;6(1):37-43.
11. Clark NM, Lynch JP. Influenza: epidemiology, clinical features,
therapy, and prevention. Paper presented at: Seminars in respiratory and
critical care medicine2011.
12. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F.
Monitoring the impact of influenza by age: emergency department fever
and respiratory complaint surveillance in New York City. PLoS
Medicine. 2007;4(8):e247.
13. Marchiori E, Zanetti G, Fontes CAP, et al. Influenza A (H1N1)
virus-associated pneumonia: High-resolution computed
tomography–pathologic correlation. European journal of
radiology. 2011;80(3):e500-e504.
14. Nicolini A, Ferrera L, Rao F, Senarega R, Ferrari-Bravo M. Chest
radiological findings of influenza A H1N1 pneumonia. Revista
Portuguesa de Pneumologia (English Edition). 2012;18(3):120-127.
15. Agarwal PP, Cinti S, Kazerooni EA. Chest radiographic and CT
findings in novel swine-origin influenza A (H1N1) virus (S-OIV)
infection. American Journal of Roentgenology.2009;193(6):1488-1493.
16. Ajlan AM, Quiney B, Nicolaou S, Muller NL. Swine-origin influenza A
(H1N1) viral infection: radiographic and CT findings. American
Journal of Roentgenology. 2009;193(6):1494-1499.
17. Rostami M, Javadi A-A, Khorvash F, et al. Thoracic computerized
tomographic (CT) findings in 2009 influenza A (H1N1) virus infection in
Isfahan, Iran. Journal of research in medical sciences: the
official journal of Isfahan University of Medical Sciences.2011;16(5):591.
18. Elicker BM, Schwartz BS, Liu C, et al. Thoracic CT findings of novel
influenza A (H1N1) infection in immunocompromised patients.Emergency radiology. 2010;17(4):299-307.
19. Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus
infection in older hospitalized persons. Journal of the American
Geriatrics Society. 2002;50(9):1498-1503.
20. Cao B, Li X-W, Mao Y, et al. Clinical features of the initial cases
of 2009 pandemic influenza A (H1N1) virus infection in China. New
England Journal of Medicine. 2009;361(26):2507-2517.
21. Hu J, Kao C, Lee P, et al. Clinical features of influenza A and B in
children and association with myositis. JOURNAL OF MICROBIOLOGY
IMMUNOLOGY AND INFECTION. 2004;37(2):95.
22. Calitri C, Gabiano C, Garazzino S, et al. Clinical features of
hospitalised children with 2009 H1N1 influenza virus infection.European journal of pediatrics. 2010;169(12):1511-1515.
23. Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, Falagas ME.
Clinical features, risk factors, and complications among pediatric
patients with pandemic influenza A (H1N1). Clinical pediatrics.2010;49(8):777-781.
24. Kaji M, Watanabe A, Aizawa H. Differences in clinical features
between influenza A H1N1, A H3N2, and B in adult patients.Respirology. 2003;8(2):231-233.
25. McDade TW, Borja JB, Kuzawa CW, Perez TLL, Adair LS. C-reactive
protein response to influenza vaccination as a model of mild
inflammatory stimulation in the Philippines. Vaccine.2015;33(17):2004-2008.
26. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein
and the risk of incident colorectal cancer. Jama.2004;291(5):585-590.
27. Morton B, Nweze K, O’connor J, et al. Oxygen exchange and C-reactive
protein predict safe discharge in patients with H1N1 influenza.QJM: An International Journal of Medicine. 2017;110(4):227-232.
28. Li W, Luo S, Zhu Y, Wen Y, Shu M, Wan C. C‐reactive protein
concentrations can help to determine which febrile infants under three
months should receive blood cultures during influenza seasons.Acta Paediatrica. 2017;106(12):2017-2024.
29. Wiwanitkit V. H7N9 influenza-the laboratory presentations: a letter
to editor. Asian Pac J Trop Biomed. 2013;3(7):584-585.
30. Soleimani G, Akbarpour M. Clinical presentation of novel influenza A
(H1N1) in hospitalized children. Iranian journal of pediatrics.2011;21(2):215.